Overview
Polysaccharides are highly hydrated polymers composed of repeating single units (monosaccharides) joined by glycosidic linkages. They can be homo-or heteropolymers and may be substituted with both organic and inorganic molecules. Polysaccharides are an incredibly diverse range of molecules by virtue of not only the different possible monosaccharide units but also how these units are joined together. The presence of a number of hydroxyl groups that may be involved in the formation of a glycosidic bond means that any two monosaccharides may be joined in a number of ways. This is in contrast to any two amino acids which can be joined together to form only one of two possible dipeptides. Additional structural complexity may be achieved by the introduction of branches into the polysaccharide chain and the substitution with both organic and inorganic molecules. Therefore, polysaccharides represent a rich source of structurally diverse molecules, many of which may have unique chemical and physical properties which have been exploited by man in a number of industrial, biomedical and food processes.
Bacterial polysaccharides are usually associated with the outer surface of the bacterium. In crude terms, these molecules can be divided into two groups. Either they may form an amorphous layer of extracellular polysaccharide surrounding the cell which may be organized into a distinct structure termed a capsule, or alternatively, the polysaccharide molecule may be more intimately associated with the cell surface either through linkage to a lipid-A moiety, as in the case of the lipopolysaccharide (LPS) molecules in Gram-negative bacteria, or linked to cell-wall techoic acids as in Gram-positive bacteria. In this review I will be focusing on capsular and extracellular polysaccharides and how these polysaccharides are currently utilized in a number of everyday processes. In addition, I will describe the important roles played by capsules in invasive bacterial infections of man. Finally, as a paradigm, I will describe the genetics and biochemistry 
The uses of bacterial polysaccharides 7be h o d industry
In general terms, polysaccharides are either used as stabilizers to maintain emulsions of oil and water containing colloidal particles or as gelling agents to alter the texture of the food. As stabilizers, polysaccharides are widely used in dried products which are reconstituted by the addition of water. The presence of the polysaccharide prevents subsequent phase separation. Many of the polysaccharides used in these products are of algal or plant origin, but in products of low pH, such as salad dressings and yoghurts, microbial xanthan is used. The use of polysaccharides to change the rheological properties of water within foods has been exploited to modify the texture of foods. Microbial polysaccharides such as xanthan and alginate are used as gel formers to change the texture of the food (Morris, 1990) . The choice of polysaccharide or mixture of polysaccharides will depend on whether a thermoreversible or thermostable gel is required and the desired consistency of the final product. In the case of alginate-based gels, the consistency of the gel depends on the relative abundance of polyguluronic acid and polymannuronic acid stretches in the polysaccharide. When polymannuronic acids predominate, the gels are more elastic and less brittle, whilst a large proportion of polyguluronic acid leads to a rigid, brittle gel (Sutherland, 1991) . Whilst much of the market is still currently taken up by plant-or animal-derived gelling agents, the susceptibility of the former to climatic influences and the unsuitability of the latter in non-meat products suggests a long-term future for microbially derived polysaccharides with the appropriate physicochemical properties.
Non-hod industrial uses of bacterial polysaccharides
Bacterial polysaccharides have been exploited in a number of non-food industrial uses. The particular application of a specific polysaccharide is a reflection of its unique IP: 54.70.40.11
On: Sat, 29 Dec 2018 07:37:59 I. S. ROBERTS physical properties. The widest non-food industrial application of bacterial derived polysaccharides is the use of xanthan in the oil industry (Moradi-Araghi e t al., 1988; Linton e t al., 1991) . Xanthan has unique rheological properties demonstrating pseudo-plastic flow and viscoelasticity, retaining its physical properties over a broad temperature range (Morris e t al., 1983; Rinaudo & Milas, 1987) . As such, xanthan has been exploited in drilling fluids to both lubricate the drill head and remove rock cuttings and in enhanced oil recovery. Other bacterial polysaccharides such as succinoglycan, which has a relatively low transition temperature have also been used in these processes (Clarke-Sturman et a/., 1989) .
Polysaccharides are used as thickeners in the printing and textile industry. The rheological properties of the polysaccharide are important in restricting the flow of the dye and in maintaining the coating of dye prior to fixation. Whilst alginates are the principal polysaccharides used in these processes, both xanthan and succinoglycan are widely used particularly in the manufacture of paints and pigments (Sutherland, 1991) .
The ability of polysaccharides to form hydrated gels has been exploited in the use of alginate-based gels for the immobilization of cells and enzymes in the biosynthesis of a number of industrial products (Skjaek-Braek & Martinsen, 1991) . Immobilized cells have the advantage of allowing a continuous throughput of substrate at relatively high cell densities. The alginate gel has to be structurally robust whilst at the same time permitting access to the substrate molecules and exit to the product. Currently, algal alginates are primarily used to make gels (Martinsen etal., 1989; Skjaek-Braek & Martinsen, 1991) . The future use of bacterially derived alginates will depend on the relative cost of such products and the initial development costs.
Biomedical uses of bacterial polysaccharides
In economic terms, the most biomedically important polysaccharide is heparin with its widespread use as an effective anticoagulant (Kjellen & Lindahl, 1991) . In addition, heparin and heparan sulphate may have important clinical applications in mediating inflammatory reactions (Lindahl e t al., 1994) and in reverting the transformed state of certain tumour cells (Mali et al., 1994) . Currently, heparin is principally derived from byproducts of the meat processing industry although the similarity between heparin and certain microbial polysaccharides may permit the synthesis of heparin in bacteria (see below).
Hyaluronic acid is a polymer of alternating glucuronic acid and N-acetylglucosamine and is an important component of the extracellular matrix (Hardingham & Muir, 1972) . In synovial fluid, hyaluronic acid is in solution with tissue-specific synovial glycoproteins which interact to provide the lubricating properties of the synovial fluid (Swann et al., 1974) . Hyaluronic acid is used in a number of surgical procedures including as a replacement for vitreous humour lost during corneal grafts (Balazs et al., 1972; Miller etal., 1977) , in the treatment of osteoarthritis (Peyron & Balazs, 1974) , and in drug delivery (Keller e t al., 1987; Ellwood, 1988) . Hyaluronic acid is extracted from tissues, particularly rooster combs and umbilical cords (Jeanloz & Forchielli, 1950; Swann, 1968) , for use in pharmaceutical products. The observation that group A and C streptococci produce hyaluronic acid capsules which are chemically identical to that found in mammals (Ruoff, 1991) has permitted the manufacture of hyaluronic acid by microbial fermentation (Chiba e t al., 1988) . Considerable efforts have been expended on developing strains which result in high yields of hyaluronic acid (Hosoya e t al., 1989) . The use of microbial fermentation offers considerable financial and ethical advantages over tissue extraction. The recent cloning and expression of the hyaluronic acid synthase gene from Streptococcxr pyugenes (Dougherty & van de Rijn, 1994) may permit the expression of this polymer in other hosts (see below).
Cellulose, a homopolymer of (l+)-D-linked glucose, is the most abundant biological polymer, Apart from being a major component of plant cell walls, cellulose is also synthesized by Acetobacter species, Bacterially derived cellulose is much purer than that extracted from plant tissue and as such it has been proposed for use in a number of medical applications including as an artificial skin, for topical drug delivery and in wound dressings (Byrom, 1991) . However, due to problems with large-scale production the use of bacterially derived cellulose has remained rather limited (Byrom, 1991) .
The most significant biomedical exploitation of bacterial polysaccharides has been in their use as vaccine agents. Capsular polysaccharides, with few exceptions, are immunogenic in non-infants, generally non-toxic and have none of the deleterious side-effects associated with whole-organism vaccines (Robbins, 1978 ; Jennings, 1990) . In addition, the use of purified polysaccharides as vaccines allows the agent in question to be precisely physically and chemically defined. Vaccines based on purified capsular polysaccharides have been generated and used effectively in the prevention of a number of bacterial infections of man. In the case of Streptococcus pnetlmoniae, the vaccine consists of 23 polysaccharides based on epidemiological data to provide the maximum effective coverage . The situation is less complex in Neisseria meningitids where serogroups A, B, C, W135 and Y are responsible for 90% of all infections (Jennings, 1990) . A tetravalent vaccine consisting of purified polysaccharides from serogroups A, C, W135 and Y is currently used as the meningococcal vaccine (Cadoz e t al., 1985) . However, despite the spectacular success of vaccines based on capsular polysaccharides there are still problems with this approach. The first is the poor immunogenicity of all polysaccharides in infants. The second is the poor immunogenicity of a few particular capsular polysaccharides in humans. Perhaps the best example of this is the group B polysaccharide of N. meningitidis which is a homopolymer of sialic acid (Bhattacharjee e t al., 1975) . The presence of sialic acid residues in oligosaccharides on the surface of human cells means that the group B polysaccharide is poorly immunogenic (Wyle Fleming Lecture et al., 1972) . To overcome this problem, chemical modification of the group B polysaccharide has been undertaken to increase its immunogenicity (Jennings, 1990) . Preliminary studies suggest that by chemical modification of the group B polysaccharide it is possible to generate antibodies specific to group B meningococci and as such this may offer a route for successful vaccine development (Jennings et al., 1993) .
To overcome the general poor immunogenicity of polysaccharides in infants, conjugate vaccines consisting of polysaccharides linked to protein carriers have been developed (Chu e t al., 1983; Beuvery et al., 1983; Kuo e t al., 1995; Lett et al., 1995) . The conjugation of polysaccharides to proteins allows an immune response to be evoked in infants and importantly such polysaccharideprotein conjugates act as T-dependent antigens thereby allowing boosting to occur upon re-exposure (Robbins & Schneerson, 1990) . A recent example of the success of such a strategy is the vaccine against Haemophilm in@eqae type b, the major cause of meningitis in children under five (Broome, 1987) . There are currently four vaccines available all of which consist of type b polysaccharide conjugated to a particular protein (Moxon & Rappouli, 1990) . The results of field trials of these vaccines are promising with all of the vaccines capable of eliciting serum antibody to type b capsule and preventing more than 90 % of all H. inji'zienxae type b disease (Eskola e t al., 1990; Santosham e t al., 1991) . These vaccines are now used routinely in many countries (Booy & Moxon, 1991) .
Functions of bacterial capsules
A number of functions have been suggested for the roles of polysaccharide capsules (Table 1) . These include protection against desiccation (Ophir & Gutnick, 1994) and mediating adhesion in biofilm formation (Costerton et al., 1981) . In invasive bacterial infections, interactions between the capsular polysaccharide and the host's immune system will be vital in deciding the outcome of the infection (Roberts et al., 1989) . The presence of a capsule is thought to confer resistance to non-specific host defence mechanisms in the absence of specific antibody. In particular, complement-mediated killing by the alternative pathway and C3b-mediated opsonophagocytosis by polymorphonuclear leukocytes (Cross, 1990) . The capsule may act in concert with other cell-surface structures, such as 0 antigens, to confer resistance to complementmediated killing (Kim et al., 1986) . Often, it is a particular combination of cell-surface structures that are responsible for conferring a high degree of resistance to complementmediated killing (Kim e t al., 1986; Cross, 1990) . By providing a permeability barrier to complement components, the capsule may mask underlying cell-surface structures which would otherwise be potent activators of the alternative pathway (Howard & Glynn, 1971) .
Capsular polysaccharides may confer resistance to complement-mediated opsonophagocytosis both by steric effects in which the capsule masks the underlying C3b deposited on cell-surface structures from C3b receptors on the phagocyte cell surface and due to the net negative charge conveyed on the cell surface by the polysaccharide capsule (Brown e t al., 1983 ; Horwitz & Silverstein, 1980 ; ). In addition, certain capsular polysaccharides are themselves poor activators of the alternative pathway (Stevens et al., 1978; Edwards et al., 1982) . Bacteria with capsular polysaccharides containing sialic acid bind factor H on their cell surface which interacts with C3b to form H-C3b thereby breaking the amplification loop of the alternative pathway . Beyond these direct interactions between the bacterial capsule and components of the host's nonspecific immune response it has been suggested that certain capsular polysaccharides may modulate the ability of the host to mediate an immune response by effecting the release of cytokine molecules thereby disrupting the coordination of the host's cell-mediated immune response (Cross et al., 1989) .
In contrast to the majority of capsular polysaccharides which are capable of eliciting an immune response, a small set of capsular polysaccharides are poorly immunogenic. These include polysaccharides containing sialic acid such as E. coli K1 or N. meningitidis serogroup B (Bhattacharjee et al., 1975) and the E. coli K5 antigen which is similar to desulpho-heparin (Vann et al., 1981) . As a consequence of structural similarities between these capsular polysaccharides and polysaccharides encountered on host tissue (Finne, 1982; Lindahl e t al., 1994) , these capsules are poorly immunogenic with infected individuals mounting a poor antibody response to the capsule (Wyle et al., 1972; Roberts e t al., 1989) . Therefore, the expression of these capsules confers some measure of resistance to the host's specific immune response. The genetics and biochemistry of capsule production in E. coli
Capsule gene clusters have been cloned from a number of both Gram-negative and positive bacteria (Roberts e t al., 1986 (Roberts e t al., , 1988 Frosch e t al., 1989; Kroll et al., 1989; Lee, 1992; De Angelis e t al., 1993; Garcia e t al., 1993; Arrecubieta et al., 1994; Dillard & Yother, 1994) . In this review, due to the constraints of space, I only intend to describe the group I1 capsule gene clusters of E. coli which in many ways can be regarded as a paradigm for other capsule gene clusters.
In excess of 70 capsular polysaccharides have been described in E. coli (0rskov et al., 1977) . On the basis of a number of biochemical and genetic criteria, E. coli capsules were originally divided into two groups, I and I1 (Jann & J a m , 1987) . Recently, this classification has been re-defined such that there are now at least three groups of capsule gene clusters (Pearce & Roberts, 1995) . By far the best studied are the group I1 capsules. The gene clusters for a number of group I1 capsules have been cloned and subjected to a detailed molecular genetic analysis (Roberts etal., 1986 (Roberts etal., , 1988 Boulnois etal., 1987; Vimr etal., 1989) . These studies have revealed that there is a common genetic organization consisting of three functional regions ( Fig. 1) (Boulnois & . Two of these regions, 1 and 3, are common to all of the group I1 capsule gene clusters so far analysed and flank a central serotypespecific region 2 (Fig. 1) . Regions 1 and 3 encode functions that are needed for the cell-surface expression of group I1 capsules albeit that these polysaccharide molecules are chemically distinct.
Region 3 contains two genes, kpsM and kpsT, organized in a single transcriptional unit (Fig. 2) (Smith e t al., 1990) . Analysis of the predicted amino acid sequences of KpsM and KpsT indicated that they are members of the family of ATP-binding cassette (ABC)-type transporters and may comprise an inner-membrane polysaccharide-export system (Smith e t al., 1990; Pavelka et al., 1991 Pavelka et al., , 1994 . Proteins homologous to both KpsM and KpsT have been identified in both H. injaenxae and N. metzingitidis and have been postulated to play an analogous role in the expression of capsules in these two species (Kroll e t al., 1990; Frosch et al., 1991) . This indicates commonality in the mechanism of capsule expression in these Gram-negative bacteria, and it has been suggested that these polysaccharide export systems may comprise a new subfamily of ABC transporters termed the ABC-2 subfamily (Reizer e t al., 1992) .
Analysis of region 1 showed the presence of six genes, kpsFEDUCS, organized in a single transcriptional unit ( , 1993b) . Therefore, it is tempting to speculate that the KpsC and S proteins may be involved in the attachment of KDO to phosphatidic acid and the subsequent ligation of the phosphatidyl-KDO to the reducing terminus of the polysaccharide prior to export across the cytoplasmic membrane by KpsM and T (Bronner e t al., 1993b) . If this is the case, this would infer that the presence of phosphatidyl-KDO at the reducing terminus of group I1
E. coli polysaccharides is the motif recognized by the proteins involved in polysaccharide export. This is an appealing notion since it might explain how a conserved set of proteins could export chemically different polysaccharide molecules independent of the repeat structure Fig. 2 . IM and OM refer to the inner-and outer membranes, respectively. The polysaccharide is shown as a jagged line and the phosphatidic acid at the reducing terminus as a diamond in the inner membrane. The initial acceptor on which polysaccharide biosynthesis occurs is depicted by a circle in the inner membrane.
On: Sat, 29 Dec 2018 07:37:59 I. S . ROBERTS (Pazzani e t al., 1993a, b) . This enzyme acts as a capsulespecific CMP-KDO synthetase enzyme to provide the CMP-KDO for the attachment of KDO to phosphatidic acid. The presence of this gene within region 1 of group I1 capsule gene clusters explains why strains expressing group I1 capsules have elevated levels of CMP-KDO synthetase activity (Finke e t al., 1990) .
In contrast to the conservation of the regions 1 and 3 between different group I1 capsule gene clusters, the capsule-specific region 2s so far analysed appear unique for a particular K antigen (Boulnois & . To date the region 2 of the K5 capsule gene cluster has been subjected to the most detailed molecular genetic analysis (Petit etal., 1995) . It contains four genes encoding proteins for the biosynthesis of the K5 polysaccharide (Fig. 2) .
Computer-aided searches of the predicted amino acid sequence of these proteins has shed some light on their likely role in the biosynthesis of the K5 polysaccharide. By over-expression of the individual genes followed by enzyme assays it has been possible to confirm the function for two of the four proteins. The KfiC protein would appear to be the K5 transferase enzyme which adds the alternating sugar residues to the growing polysaccharide chain, whilst the KfiD protein is a UDP-glucose dehydrogenase enzyme which catalyses the production of UDP-glucuronic acid a component of the K5 polysaccharide (Petit et al., 1995) . The functions of the KfiA and B proteins are so far unknown, but it may be that they participate in the initial stages of polysaccharide biosynthesis (K. Jann & I. S. Roberts, unpublished results) . By bringing together all of these data it has been possible to propose a model to explain K5 polysaccharide biosynthesis and how group I1 polysaccharides may be exported onto the cell surface in E. coli (Fig. 3) . Clearly, there are still a lot of unanswered questions. What is the acceptor on which the K5 polysaccharide is synthesized? How is the export of polysaccharide molecules across two membranes achieved? Are sites of membrane adhesion, socalled Bayer junctions, important in this process? How is this large polysaccharide-synthesizing multiprotein complex maintained on the membrane? This model represents a start point from which a clearer picture can be further defined with increasing experimental evidence.
Polysaccharide engineering in bacteria
The widespread application of polysaccharides in a number of biomedical and industrial processes raises the question of whether it is feasible to attempt to synthesize these molecules in an heterologous host such as E. coli.
The possibility of being able to generate polysaccharide molecules with desired physical and chemical properties is appealing. This is particularly so with polysaccharides of non-microbial origin which may have to be purified from animal tissue by lengthy extraction procedures. One such an example is heparin. The structural similarity between the E. coli K5 polysaccharide, which has the same sugar backbone as heparin but is neither N-deacetylated nor Nsulphated (Vann etal., 1981) , offers a possible route for the biosynthesis of this medically important molecule in E.
coli. The recent cloning and expression in E. coli of the gene from S. PJyogeneS encoding the hyaluronic acid synthase (Dougherty & van de Rijn, 1994) may permit the expression of large amounts of hyaluronic acid in E. coli. Whether this will offer any commercial advantages over the current production methods using group A and C streptococci is not yet known.
The use of E. coli polysialyltransferase enzyme from the K1 capsule gene cluster to synthesize polysialylated neoglycosphingolipids of pharmacological importance (Cho & Troy, 1994 ) is another example of how polysaccharide engineering may be achieved using an E. coli glycosyltransferase. The diversity of capsular polysaccharides in E. coli means that there is a potential store of glycosyltransferases waiting to be exploited. By judicious choice of the glycosyltransferase genes that are cloned and co-expressed in the same cell it may be possible to construct novel polysaccharides with desired physical and chemical properties. Clearly, if these interesting ideas are to be pursued then a greater understanding of how polysaccharides are synthesized and exported in E. coli will be essential.
Concluding remarks
Polysaccharides are an incredibly diverse range of biologically important molecules. They play vital roles in mediating a broad range of biological processes. Clearly, a greater understanding of how polysaccharides are synthesized and exported in bacteria will be important in allowing us to synthesize in bacteria polysaccharides of industrial and pharmaceutical importance. Of equal significance is that an understanding of polysaccharide capsule production in pathogenic micro-organisms may permit the rational design of specific inhibitors of this process which may be used as chemotherapeutic agents. Hopefully over the next few years we can make significant progress in both these general areas.
